Cell Biologics, Inc.
Chicago, IL
- UEI
- MXRXU574VRM7
- CAGE
- 6MR36
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2201 W Campbell Park Dr #326, Chicago, IL 60612, USA
- Website
- cellbiologics.com
- Founded
- 2010
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Human primary colonic epithelia cells | Office of Research and Development (EPA) | $12,765 | |
| Human primary colonic epithelia cells | Office of Research and Development (EPA) | $24,595 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| HLS13-13 albumin nanoparticle based technology to treat ards | National Heart Lung and Blood Institute (NIH) | $668,170 | |
| Cblb-based drugs against sepsis and inflammation | National Institutes of Health | $218,510 |
Quick answers
Is Cell Biologics, Inc. registered in SAM.gov?
Yes. Cell Biologics, Inc.'s SAM.gov registration is active through August 19, 2027.
What is Cell Biologics, Inc.'s most recent federal award?
Cell Biologics, Inc.'s most recent federal contract award is Human primary colonic epithelia cells (EP17Z000174), from Office of Research and Development (EPA), on August 3, 2017.
On GovTribe
See Cell Biologics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors